Target intelligence / Profile preview

WD repeat and FYVE domain-containing protein 1 (WDFY1)

Target
WDFY1
Molecular classification
Adaptor protein, WD repeat domain containing protein, Zinc finger protein (FYVE domain), Phosphoinositide-binding protein, Endosomal protein
01

Overview

WD repeat and FYVE domain-containing protein 1 (WDFY1) is a phosphatidylinositol 3-phosphate binding adaptor protein containing multiple WD-40 repeat domains and a FYVE zinc finger domain, which localizes to early endosomes via its FYVE domain. WDFY1 is a crucial mediator of innate immune signaling, specifically by bridging Toll-like receptors TLR3 and TLR4 to the TRIF (also known as TICAM1) adaptor, resulting in the activation of transcription factors IRF3 and NF-κB and the production of type I interferons and inflammatory cytokines. The protein also plays a significant role in cancer cell biology, operating downstream of Neuropilin-2 (NRP2) to regulate endocytic and autophagic trafficking. WDFY1 expression must be tightly regulated for optimal cell survival and oncogenic signaling, and it may be involved in neurodegenerative processes (e.g., Alzheimer’s disease) where it is linked to senile plaque formation and transcriptional regulation through the FAC1 repressor. Collectively, WDFY1 serves as a molecular bridge in both immune and cancer-related signaling pathways, making it a potential therapeutic target in immunological and oncogenic diseases.

Other names
FENS1FENS-1KIAA1435WDF1ZFYVE17FYVE domain-containing protein localized to endosomes 1Phosphoinositide-binding protein 1WD40- and FYVE domain-containing protein 1zinc finger FYVE domain-containing protein 17phosphoinositide-binding protein SR1
02

Mechanism of action

no established drug mechanisms for WDFY1; its function is relevant to TLR3/4 signaling modulation

03

Biological functions

Innate immune signaling adaptor (bridges TLR3/TLR4 to TRIF/TICAM1 signaling)Potentiates NF-κB and IRF3 activationPromotes type I interferon and inflammatory cytokine productionModulates endocytic and autophagic pathways, especially in cancer cells
04

Disease associations

Cancer (regulation of endocytosis and autophagy in metastatic cells)Immune/inflammatory responsesRett syndromeBasan syndromeNeurodegenerative disease (Alzheimer’s disease—senile plaque formation, transcriptional regulation)
05

Biomarkers

overexpression has associations with Alzheimer’s plaque formation and can be measured in tissue-specific contexts

Beyond the preview

Go deeper on WD repeat and FYVE domain-containing protein 1 (WDFY1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat and FYVE domain-containing protein 1 (WDFY1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call